| Literature DB >> 30824830 |
Giulia Cappagli1, Sara Finocchietti1, Elena Cocchi2, Giuseppina Giammari3, Roberta Zumiani4, Anna Vera Cuppone1, Gabriel Baud-Bovy5,6, Monica Gori7.
Abstract
Since it has been demonstrated that spatial cognition can be affected in visually impaired children, training strategies that exploit the plasticity of the human brain should be early adopted. Here we developed and tested a new training protocol based on the reinforcement of audio-motor associations and thus supporting spatial development in visually impaired children. The study involved forty-four visually impaired children aged 6-17 years old assigned to an experimental (ABBI training) or a control (classical training) rehabilitation conditions. The experimental training group followed an intensive but entertaining rehabilitation for twelve weeks during which they performed ad-hoc developed audio-spatial exercises with the Audio Bracelet for Blind Interaction (ABBI). A battery of spatial tests administered before and after the training indicated that children significantly improved in almost all the spatial aspects considered, while the control group didn't show any improvement. These results confirm that perceptual development in the case of blindness can be enhanced with naturally associated auditory feedbacks to body movements. Therefore the early introduction of a tailored audio-motor training could potentially prevent spatial developmental delays in visually impaired children.Entities:
Year: 2019 PMID: 30824830 PMCID: PMC6397231 DOI: 10.1038/s41598-019-39981-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1ABBI, the Audio Bracelet for Blind Interaction, is a small wearable custom-designed technology with integrated audio system, motion sensors, and a Bluetooth low energy module to communicate with a smartphone. The core idea behind ABBI is to use the auditory modality to convey spatial information about the movement of the person’s own body within the personal, peri-personal and extra-personal space.
Clinical details of the participants.
| Sex | Age | Pathology | Visual Acuity | Onset |
|---|---|---|---|---|
|
| ||||
| F | 6 | Retinopathy of prematurity | Light perception | Congenital |
| M | 6 | Ocular albinism | 1 | Congenital |
| M | 7 | Neurofibromatosis type I | 1.7 | Acquired |
| M | 8 | Leber’s amaurosis | 1 | Congenital |
| F | 8 | Microphtalmia | 1 | Acquired |
| F | 9 | Retinopathy of prematurity | Light perception | Congenital |
| F | 9 | Retinopathy of prematurity | None | Congenital |
| F | 9 | Retinopathy of prematurity | Light perception | Congenital |
| M | 10 | Tuberculous meningitis | Light perception | Congenital |
| M | 10 | Optic nerve glioma | 0.1 | Congenital |
| F | 11 | Nystagmus | 0.7 | Acquired |
| F | 12 | Congenital cataract and microphtalmia | Light perception | Congenital |
| F | 12 | Retinopathy of prematurity | Light perception | Congenital |
| M | 13 | Optic nerve glioma | 0.7 | Acquired |
| F | 13 | Stargardt’s Macular Distrophy | 1 | Acquired |
| F | 14 | Leber’s amaurosis | Light perception | Congenital |
| F | 14 | Optic nerve atrophy | 1 | Congenital |
| F | 14 | Optic nerve atrophy | 1.7 | Acquired |
| F | 15 | Retinopathy of prematurity | None | Congenital |
| M | 15 | Retinopathy of prematurity | None | Congenital |
| F | 16 | Cones dystrophy | Light perception | Congenital |
| M | 17 | Leber’s amaurosis | Light perception | Congenital |
|
| ||||
| M | 6 | Retinal dystrophy | 2 | Acquired |
| M | 6 | Albinism | 1.3 | Congenital |
| M | 7 | Albinism | 1 | Congenital |
| M | 7 | Norrie syndrome | Light perception | Congenital |
| F | 7 | Complex ocular malformation | Light perception | Congenital |
| M | 8 | Retinal dystrophy | 1.3 | Congenital |
| M | 8 | Achromatopsia | 1.3 | Congenital |
| F | 9 | Congenital nystagmus | 1 | Congenital |
| F | 9 | Optic atrophy | Light perception | Congenital |
| F | 9 | Astrocytomas | 1.3 | Acquired |
| M | 10 | Retinal dystrophy | 1.22 | Acquired |
| M | 10 | BiAcquiredral retinoblastoma | 2 | Congenital |
| F | 11 | Achromatopsia | 1 | Congenital |
| F | 11 | Leber’s amaurosis | 2 | Congenital |
| M | 11 | Lyell syndrome | 1.3 | Acquired |
| F | 12 | Retinal dystrophy | 1 | Congenital |
| F | 12 | Optical nerves hypoplasia | 1.7 | Congenital |
| M | 13 | Retinal dystrophy | 1.22 | Congenital |
| F | 13 | Retinopathy of prematurity | 1 | Congenital |
| M | 13 | Optic atrophy | 1 | Acquired |
| M | 15 | Retinal dystrophy | 1.22 | Acquired |
| F | 15 | Maculopathy | 1.3 | Acquired |
Twenty-two (14 females, mean age 11 +/− 3) children participated in the ABBI intervention, and twenty-two (10 females, mean age 10 +/− 3) children participated in the Classical intervention. The table shows the gender, the age at test, the principal diagnosis, the visual acuity expressed as LogMAR and the onset of visual disfunction.
Figure 2CONSORT diagram with participant flow.
Score difference (Δ) after 12 weeks training (T1-T0).
| ABBI group (ΔA = T1 − T0, N = 18) | Control group (ΔC = T1 − T0, N = 20) | ABBI vs Control (ΔΑ − ΔC) p value | ABBI group follow-up (ΔA2 = T2 − T0, N = 10) | ABBI-Follow-up vs ABBI (ΔA − ΔA2) p value | |
|---|---|---|---|---|---|
| Auditory localization [deg] | 2.80 (1.48)** | 1.15 (0.78) | 0.0001* | 3.83 (2.22) | 0.17 |
| Auditory bisection [deg] | 2.43 (2.12)*** | 0.15 (0.66) | 0.0005* | 3.18 (2.83) | 0.11 |
| Auditory distance [deg] | 0.88 (2.41) | 0.98 (1.66) | 0.62 | 3.06 (1.93) | 0.99 |
| Auditory reaching [cm] | 25.48 (12.12)*** | 3.95 (12.19) | 0.0005** | 17.12 (9.89) | 0.17 |
| Proprioceptive reaching [cm] | 16.44 (10.40)*** | 9.89 (7.18) | 0.01** | 23.78 (17.92) | 0.66 |
| General mobility [s] | 3.53 (2.59)** | 1.94 (0.95) | 0.04* | 2.97 (2.78) | 0.44 |
One year follow-up of the ABBI group (T2-T0). Data are presented as mean and standard deviation. The stars indicate the statistical significance of the corresponding t-test of the score difference (*p < 0.05; **p < 0.01; ***p < 0.001).